|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
 |
Case ID: 4834 | Drugs / Medical | 06/07/2006
Lawyers filed a class-action lawsuit against Kaiser Permanente on behalf of patients of the HMO's troubled kidney-transplant program, which shut down in May 2006 amid federal and state investigations. The complaint, filed in San Francisco Superior Court, accuses Kaiser of fraud, negligence and mismanagement in its ability to properly administer the kidney transplant program, which included 2,000 patients in Northern California.
Federal and state health officials are investigating whether patients were harmed after Kaiser launched the program in 2004. An investigation performed by the Los Angeles Times found that patients received half as many transplants at Kaiser than at other kidney transplant programs in the state. "This is an outrageous example of gross mismanagement at the highest level," said the attorney who filed the lawsuit, in a statement. When Kaiser began the program, the HMO required all members waiting for a kidney transplant to switch to the new program from the University of California, San Francisco and the University of California, Davis, where they were previously receiving care. However, bungled paperwork may have cost some patients time on the waiting list for a kidney match, delaying transplants. Patients also reported that Kaiser was unresponsive to their needs. "It is clear that Kaiser patients did not receive proper medical care and kidney transplants were delayed," said the lead attorney, who is also representing transplant patients in litigation against the University of California, Irvine Medical Center. The class-action lawsuit is the latest in a series of legal actions filed against Kaiser since its transplant program came under scrutiny. At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints. Other Drugs / Medical Cases of Interest The parties have reached a $750,000 settlement in an FTC administrative proceeding filed against dietary supplement marketer VisionTel Communications, LLC, on behalf of all persons who purchased Chito-Trim or TurboTone for weight loss, or Impulse Female Herbal Blend/ Maximus Male Herbal Blend for male and female sexual dysfunction. The action alleged that the marketers made deceptive advertising claims about these products in violation of federal consumer protection laws. Persons eligible to take part in the settlement should contact the prosecuting attorneys for more information. The Food and Drug Administration today updated labeling for the Ortho Evra contraceptive patch to warn healthcare providers and patients that this product exposes women to higher levels of estrogen than most birth control pills. Ortho Evra was the first skin patch approved for birth control. Several class actions have been filed against biopharmaceutical corporation Adolor Corporation (Nasdaq:ADLR) and certain of its officers and directors by stockholders who purchased the company's common stock between September 23, 2003, and January 14, 2004. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. Several class actions have been filed against hedge fund operator Durus Capital Management, LLC, Durus Life Sciences Master Fund, Ltd., Scott Sacane, and Aksys, Ltd., by stockholders who sold short shares of Aksys, Ltd., (Nasdaq:AKSY) between January 1, 2003, to July 24, 2003. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially deflating the price of the company's securities. In this day of incurable transmissible diseases, it would be nice to be confident that the needle that gets stuck in your arm has never been used before. On November 5, 2003, the court granted preliminary approval to the parties' $25 million proposed settlement in a class action filed against Oklahoma's Norman Regional Hospital, a clinic administrator, and nurse anesthetist James Hill who is accused of reusing needles when administering intravenous pain medicine to patients in the hospital's clinic in violation of state medical regulations. Several class actions have been filed against temporary nurse staffing company Cross Country Healthcare, Inc., (Nasdaq:CCRN) and certain of its officers and directors by stockholders who purchased the company's common stock between October 25, 2001, and August 6, 2002. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. |
IT'S FREE
|
© 2000 - 2008 Copyright. All rights reserved nola3, llc.
